Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “cannabidiol”

18 pharma patents match "cannabidiol" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 18
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 18 pharmaceutical patents matching "cannabidiol" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

18 results for “cannabidiol” · 30,257 patents in full index Clear search

  1. US 12396963

    Cannabidiol-type cannabinoid compound

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted
  2. US 12383512

    Cannabidiol-type cannabinoid compound

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  3. US 12364670

    Cannabidiol-type cannabinoid compound

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  4. US 12357586

    Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  5. US 12263139

    Use of cannabidiol in the treatment of tuberous sclerosis complex

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  6. US 12226373

    Treatment of fragile X syndrome with cannabidiol

    Harmony Biosciences Management, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  7. US 12213951

    Treatment of autism with cannabidiol

    Harmony Biosciences Management, Inc. · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  8. US 12186282

    Treatment of 22Q11.2 deletion syndrome with cannabidiol

    Harmony Biosciences Management, Inc. · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  9. US 12102619

    Methods of treating tuberous sclerosis complex with cannabidiol and everolimus

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  10. US 11826428

    Solid solution compositions comprising cannabidiols

    Infirst Healthcare Limited · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  11. US 11712474

    Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition

    Regen Biopharma, Inc. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  12. US 11364202

    Solid forms of cannabidiol and uses thereof

    Artelo Biosciences, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  13. US 11285184

    Cannabidiol alkaline composition

    CHIROSYN DISCOVERY TECHNOLOGIES INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  14. US 10870632

    Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts

    BIONORICA ETHICS GMBH · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  15. US 10722581

    Phonophoretic cannabidiol composition and transdermal delivery system

    Essential Green Goodness LLC · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  16. US 10604467

    Solid forms of cannabidiol and uses thereof

    Artelo Biosciences, Inc. · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  17. US 10398776

    Phonophoretic cannabidiol composition and transdermal delivery system

    Essential Green Goodness LLC · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted
  18. US 8895078

    Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts

    BIONORICA ETHICS GMBH · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted